Circulating lymphotoxin β receptor and atherosclerosis: Observations from the Dallas Heart Study

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 601-606

  Owens, Andrew W ^a   Matulevicius, Susan ^a   Rohatgi, Anand ^a   Ayers, Colby R ^a   Das, Sandeep R ^a   Khera, Amit ^a   McGuire, Darren K ^a   de Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aortic plaque; Atherosclerosis; Biomarker; Coronary calcium; LT R; Lymphotoxin

Indexed keywords

CALCIUM; LYMPHOTOXIN BETA RECEPTOR;

ADULT; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY BLOOD VESSEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INJURY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNIVARIATE ANALYSIS;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOCYTES; LYMPHOTOXIN BETA RECEPTOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; REGRESSION ANALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957723199     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.06.003     Document Type: Article

References (30)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
2. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
3. Tumanov A.V., Christiansen P.A., Fu Y.X. The role of lymphotoxin receptor signaling in diseases. Curr Mol Med 2007, 7:567-578.
4. Ozaki K., Ohnishi Y., Iida A., et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002, 32:650-654.
5. Lee W.H., Kim S.H., Lee Y., et al. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 2001, 21:2004-2010.
6. Victor R.G., Haley R.W., Willett D.L., et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004, 93:1473-1480.
7. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005, 46:464-469.
8. Abdullah S.M., Khera A., Das S.R., et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol 2005, 96:1284-1289.
9. Deo R., Khera A., McGuire D.K., et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004, 44:1812-1818.
10. Rohatgi A., Ayers C.R., Khera A., et al. The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: observations from the Dallas Heart Study. Atherosclerosis 2009, 203:569-575.
11. Matulevicius S., Rohatgi A., Khera A., et al. The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study. Apoptosis 2008, 13:1281-1289.
12. Abedin M., Omland T., Ueland T., et al. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am J Cardiol 2007, 99:513-518.
13. de Lemos J.A., Zirlik A., Schonbeck U., et al. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol 2005, 25:2192-2196.
14. Zirlik A., Abdullah S.M., Gerdes N., et al. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol 2007, 27:2043-2049.
15. Jain T., Peshock R., McGuire D.K., et al. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J Am Coll Cardiol 2004, 44:1011-1017.
16. Jaffer F.A., O'Donnell C.J., Larson M.G., et al. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002, 22:849-854.
17. ® users group international conference 2001, SAS Institute, Inc., Cary (NC).
18. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
19. Laman J.D., Schoneveld A.H., Moll F.L., van Meurs M., Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am J Cardiol 2002, 90:119-123.
20. Gommerman J.L., Browning J.L. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 2003, 3:642-655.
21. Scholz H., Sandberg W., Damas J.K., et al. Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis. Circulation 2005, 112:2121-2129.
22. Liu G.Z., Fang L.B., Hjelmstrom P., Gao X.G. Enhanced plasma levels of LIGHT in patients with acute atherothrombotic stroke. Acta Neurol Scand 2008, 118:256-259.
23. Grabner R., Lotzer K., Dopping S., et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med 2009, 206:233-248.
24. Clarke M.C., Figg N., Maguire J.J., et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006, 12:1075-1080.
25. Chen M.C., Hsu T.L., Luh T.Y., Hsieh S.L. Overexpression of bcl-2 enhances LIGHT- and interferon-gamma-mediated apoptosis in Hep3BT2 cells. J Biol Chem 2000, 275:38794-38801.
26. Klingenberg R., Hansson G.K. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 2009, 30:2838-2844.
27. Budoff M.J., Georgiou D., Brody A., et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 1996, 93:898-904.
28. Rumberger J.A., Schwartz R.S., Simons D.B., et al. Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy. Am J Cardiol 1994, 73:1169-1173.
29. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995, 92:2157-2162.
30. Schmermund A., Baumgart D., Gorge G., et al. Measuring the effect of risk factors on coronary atherosclerosis: coronary calcium score versus angiographic disease severity. J Am Coll Cardiol 1998, 31:1267-1273.